杭州景业智能科技股份有限公司 关于预计 2024 年度日常性关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 是否需要提交股东大会审议：是 日常关联交易对上市公司的影响：本次杭州景业智能科技股份有限公司 （以下简称"公司"）预计 2024 年度日常性关联交易系公司业务发展及生产经 营实际需要，交易定价依据市场价格确定，不存在损害公司及全体股东特别是中 小股东利益的行为，公司不会因上述交易而对关联方形成较大依赖，不会影响公 司的独立性。 一、日常关联交易基本情况 证券代码：688290 证券简称：景业智能 公告编号：2024-017 （一）日常关联交易履行的审议程序 公司于 2024 年 4 月 22 日召开第二届董事会第四次会议、第二届监事会第三 次会议，审议通过了《关于预计 2024 年度日常性关联交易的议案》，本次日常 关联交易预计金额合计为 35,000 万元人民币。董事会审议该议案时，关联董事 冯守佳对该议案回避表决，出席会议的其他非关联董事一致同意通过该议案，审 议程序符合相关法律法 ...

目 录 （四）母公司利润表………………………………………………第 10 页 （五）合并现金流量表……………………………………………第 11 页 （六）母公司现金流量表…………………………………………第 12 页 （七）合并所有者权益变动表……………………………………第 13 页 （八）母公司所有者权益变动表…………………………………第 14 页 三、财务报表附注…………………………………………………第 15—93 页 四、证书附件………………………………………………………第 94—97 页 审 计 报 告 天健审〔2024〕3261 号 杭州景业智能科技股份有限公司全体股东： 一、审计意见 我们审计了杭州景业智能科技股份有限公司（以下简称景业智能公司）财务 报表，包括 2023 年 12 月 31 日的合并及母公司资产负债表，2023 年度的合并及 母公司利润表、合并及母公司现金流量表、合并及母公司所有者权益变动表，以 及相关财务报表附注。 我们认为，后附的财务报表在所有重大方面按照企业会计准则的规定编制， 公允反映了景业智能公司2023年12月 31日的合并及母公司财务状况，以及2023 年度的合并及母公司 ...

（二）投资者保护能力 截至2023年末，天健所累计已计提职业风险基金1亿元以上，购买的职业保险累 计赔偿限额超过1亿元，职业风险基金计提及职业保险购买符合财政部关于《会计师 事务所职业风险基金管理办法》等文件的相关规定。天健近三年未因执业行为在相 关民事诉讼中被判定需承担民事责任。 （一）资质条件 截止2023年12月31日，天健所基本情况如下： | 事务所名称 | 天健会计师事务所（特殊普通合伙） | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 成立日期 | 2011 年 月 日 组织形式 | 7 | 18 | | 特殊普通合伙 | | | 注册地址 | 浙江省杭州市西湖区灵隐街道西溪路 128 | | | 号 | | | | 首席合伙人 | 王国海 上年末合伙人数量 | | | | 238 | 人 | | 上年末执业人员数量 | 注册会计师 | | | | 2,272 | 人 | | | 签署过证券服务业务审计报告的注册会计师 | | | | 836 | 人 | | 2023 年（经审计） | 业务收入总额 34.83 | | | 亿元 ...

关于杭州景业智能科技股份有限公司 非经营性资金占用及其他关联资金往来情况 汇总表的专项审计报告 目 录 1、 专项审计报告 2、 附表 委托单位：杭州景业智能科技股份有限公司 审计单位：天健会计师事务所（特殊普通合伙） 联系电话：0571-88216888 目 录 非经营性资金占用及其他关联资金往来情况的 专项审计说明 天健审〔2024〕3263 号 杭州景业智能科技股份有限公司全体股东： 我们接受委托，审计了杭州景业智能科技股份有限公司（以下简称景业智 能公司）2023 年度财务报表，包括 2023 年 12 月 31 日的合并及母公司资产负 债表，2023 年度的合并及母公司利润表、合并及母公司现金流量表、合并及母 公司所有者权益变动表，以及财务报表附注，并出具了审计报告。在此基础上， 我们审计了后附的景业智能公司管理层编制的 2023 年度《非经营性资金占用及 其他关联资金往来情况汇总表》（以下简称汇总表）。 一、非经营性资金占用及其他关联资金往来情况的专项 审计说明…………………………………………………………第 1—2 页 二、非经营性资金占用及其他关联资金往来情况汇总表…………… 第 3 页 一、对 ...

Financial Performance - The company's operating revenue for Q1 2024 was ¥23,259,702.77, representing a decrease of 55.26% compared to the same period last year[5]. - The net profit attributable to shareholders was -¥11,174,381.18, a decline of 292.05% year-over-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥14,253,856.23, reflecting a decrease of 396.64%[5]. - Total revenue for Q1 2024 was CNY 23,259,702.77, a decrease of 55.32% compared to CNY 51,986,198.23 in Q1 2023[20]. - Net profit for Q1 2024 was a loss of CNY 11,655,832.27, compared to a profit of CNY 5,818,441.56 in Q1 2023[21]. - Operating profit for Q1 2024 was a loss of CNY 12,126,160.96, compared to a profit of CNY 5,189,059.34 in Q1 2023[21]. - The total comprehensive income attributable to the parent company for Q1 2024 was -11,174,381.18 CNY, compared to 5,818,441.56 CNY in Q1 2023[22]. - Basic and diluted earnings per share for Q1 2024 were both -0.10 CNY, down from 0.07 CNY in Q1 2023[22]. Cash Flow - The net cash flow from operating activities was -¥31,753,949.04, an increase of 48.86% compared to the previous year[5]. - Cash inflows from operating activities totaled 48,127,406.00 CNY in Q1 2024, an increase from 39,704,924.31 CNY in Q1 2023[22]. - Cash outflows from operating activities were 79,881,355.04 CNY in Q1 2024, down from 101,793,160.70 CNY in Q1 2023[22]. - The net cash flow from operating activities improved to -31,753,949.04 CNY in Q1 2024, compared to -62,088,236.39 CNY in Q1 2023[22]. - Cash inflows from investing activities were 233,288,632.78 CNY in Q1 2024, down from 381,159,549.40 CNY in Q1 2023[23]. - The net cash flow from investing activities increased to 115,340,443.55 CNY in Q1 2024, compared to 67,324,789.87 CNY in Q1 2023[23]. - Cash inflows from financing activities were 15,144,068.00 CNY in Q1 2024, with cash outflows totaling 20,000,094.02 CNY[23]. - The net increase in cash and cash equivalents for Q1 2024 was 78,730,468.49 CNY, compared to 3,787,093.94 CNY in Q1 2023[23]. - The ending balance of cash and cash equivalents for Q1 2024 was 289,967,601.65 CNY, up from 176,552,998.66 CNY in Q1 2023[23]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,489,631,767.64, down 5.21% from the end of the previous year[6]. - The company's current assets totaled RMB 1,017,112,352.99, down from RMB 1,097,542,202.81, indicating a decrease of about 7.3%[17]. - The company's accounts receivable stood at RMB 188,719,870.26, slightly down from RMB 192,180,304.40, showing a decrease of about 1.9%[17]. - Inventory increased to RMB 102,072,666.71 from RMB 97,102,228.63, marking an increase of approximately 5.9%[17]. - The total non-current assets were RMB 472,519,414.65, a slight decrease from RMB 474,045,546.65, reflecting a decline of about 0.3%[17]. - The company's total liabilities decreased to CNY 257,845,974.50 in Q1 2024 from CNY 309,482,671.77 in Q1 2023[19]. - Shareholders' equity attributable to the parent company decreased to CNY 1,229,901,520.91 in Q1 2024 from CNY 1,259,739,354.37 in Q1 2023[19]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 3,479[10]. - The largest shareholder, Hangzhou Xingzhiyuan Holdings Co., Ltd., held 28,661,917 shares, representing 28.05% of the total shares[10]. - The top shareholder, Hangzhou Yimi Investment Partnership, held 8,866,952 shares, representing 8.68% of the total shares[12]. - The company reported a total of 1,058,585 shares held by the Dachen Leading Mixed Securities Investment Fund as of the latest report[11]. - The company has not reported any significant changes in its major shareholders due to the transfer of shares in the current reporting period[14]. Research and Development - Research and development expenses totaled ¥8,712,192.92, accounting for 37.46% of operating revenue, an increase of 17.43 percentage points[6]. - Research and development expenses for Q1 2024 were CNY 8,712,192.92, down from CNY 10,413,902.73 in Q1 2023[20]. Government Support - The company received government subsidies amounting to ¥930,000.00 during the reporting period[7]. Strategic Focus - There were no new strategies or product developments mentioned in the conference call, focusing primarily on financial performance and shareholder structure[15]. - The company plans to focus on market expansion and new product development in the upcoming quarters[20].

Financial Performance - The company achieved a net profit attributable to shareholders of RMB 34.6868 million for the year 2023, with an undistributed profit of RMB 214.5895 million at year-end [5]. - In 2023, the company's operating revenue was CNY 255.44 million, a decrease of 44.89% compared to CNY 463.49 million in 2022 [21]. - The net profit attributable to shareholders was CNY 34.69 million, down 71.47% from CNY 121.56 million in the previous year [21]. - Basic earnings per share decreased by 73.48% to CNY 0.35 from CNY 1.32 in 2022 [23]. - The cash flow from operating activities was CNY 22.33 million, a decline of 57.41% from CNY 52.45 million in the previous year [22]. - The total amount of non-recurring gains and losses for 2023 was 18,429,070.03 RMB, compared to 22,377,932.14 RMB in 2022 [30]. - The net profit after deducting non-recurring gains and losses was CNY 16.26 million, a decline of 83.61% year-on-year [102]. - The comprehensive gross margin for the reporting period was 47.84%, indicating a stable performance despite market challenges [98]. Profit Distribution - The proposed profit distribution plan includes a cash dividend of RMB 1.06 per 10 shares (tax included), totaling RMB 10.7787 million, which accounts for 31.07% of the net profit attributable to shareholders for 2023 [5]. - The profit distribution proposal requires approval from the 2023 annual general meeting of shareholders [192]. Audit and Governance - The company has received a standard unqualified audit report from Tianjian Accounting Firm [5]. - The board of directors has confirmed the authenticity, accuracy, and completeness of the annual report [4]. - The company has established a comprehensive internal control system, enhancing risk management and operational efficiency [197]. - The internal control audit report for the year 2023 received a standard unqualified opinion [199]. - The company has established a sound governance structure and internal control system, ensuring independence from its controlling shareholder [154]. Research and Development - Research and development expenses accounted for 15.89% of operating revenue, an increase of 6.75 percentage points from 9.14% in 2022 [23]. - The total R&D expenditure for the year was approximately ¥40.59 million, a decrease of 4.16% compared to the previous year, with R&D expenses accounting for 15.89% of operating revenue, an increase of 6.75 percentage points [75]. - The company is actively involved in the research and development of intelligent robots and specialized equipment, aligning with national policies that support the robotics industry [141]. - The company is committed to continuous innovation, focusing on high-quality, reliable products tailored to meet the specific needs of the nuclear and military sectors [86]. Market and Industry Trends - The nuclear fuel sector has shown growth, while non-nuclear business areas have also made breakthroughs, indicating a solid step in new business layouts [36]. - The market size of China's nuclear technology application industry has grown from 300 billion yuan in 2015 to nearly 700 billion yuan by the end of 2022, with an average annual growth rate exceeding 15%, and is expected to reach a trillion yuan by 2025 [58]. - The demand for industrial robots is increasing due to the transformation and upgrading of the manufacturing industry, with a significant market potential for special robots designed for extreme environments and emergency rescue [66]. - The integration of AI, big data, and IoT technologies is enhancing the intelligence level of robots, enabling them to perform more complex tasks and improve human-robot collaboration [67]. Strategic Initiatives - The company has initiated its second five-year development strategy ("135" development strategy) to focus on high-quality intelligent manufacturing solutions in the nuclear industry [34]. - The company plans to continue investing in R&D and maintaining personnel costs to ensure project delivery despite the revenue decline [24]. - The company is exploring new business models such as leasing and customization to reduce costs and meet specific industry needs [66]. - The company aims to increase the localization of nuclear equipment to reduce construction and operational costs, supporting sustainable development in the nuclear sector [64]. Operational Efficiency - The company has implemented five upgrades in its operational model, enhancing overall customer service capabilities and project delivery efficiency [38]. - The procurement strategy is based on just-in-time ordering, minimizing inventory while ensuring quality through a qualified supplier management system [54]. - The production model is project-based, focusing on custom products tailored to specific client orders, ensuring efficient resource allocation [55]. Risk Management - The company has not reported any significant risks that could materially affect its operations during the reporting period [4]. - The company faces risks related to customer demand changes and potential loss of core technical talent, which could impact its competitive position [93]. Employee and Management Structure - The company employed a total of 371 staff, with 283 in the parent company and 88 in major subsidiaries [185]. - The workforce includes 148 R&D personnel, 115 production staff, and 16 sales staff, indicating a strong focus on research and development [185]. - The company has established a high-level R&D team, with technical R&D personnel making up about 40% of the total workforce [87]. Shareholder Engagement - The company held 1 annual general meeting and 2 extraordinary general meetings during the reporting period, ensuring all shareholders, especially minority shareholders, could exercise their voting rights [151]. - The company has maintained effective communication mechanisms with investors, ensuring their rights to information and participation [200].

作为杭州景业智能科技股份有限公司（以下简称"公司"）的独立董事，本 人按照《公司法》《证券法》《上市公司独立董事规则》等有关规定，本着对公司 和股东负责的态度，忠实、勤勉、尽责地履行职务，积极出席相关会议，认真审 议董事会各项议案，充分发挥独立董事的独立性和专业性作用，切实维护了公司 和股东尤其是中小股东的利益。现将2023年的工作情况汇报如下： 杭州景业智能科技股份有限公司 2023 年度独立董事述职报告 一、独立董事基本情况 （一）工作履历、专业背景以及兼职情况 杨将新，男，中国国籍，无境外永久居留权。毕业于浙江大学机械制造及 自动化专业，博士学位。全国产品尺寸和几何量技术规范标准化技术委员会副 主任委员、全国高校互换性与测量技术研究会副理事长、浙江省机械工程学会 生产工程分会理事长。自 2021 年 1 月至今，任杭州景业智能科技股份有限公司 独立董事。 （二）是否存在影响独立性的情况说明 作为公司的独立董事，本人未在公司担任除独立董事外的其他任何职务， 与公司以及公司主要股东不存在可能妨碍进行独立客观判断的关系，也未受过中 国证监会及证券交易所的任何惩戒，在履职中始终保持独立客观的专业判断，不 存在任 ...

证券代码：688290 证券简称：景业智能 公告编号：2024-016 杭州景业智能科技股份有限公司 关于续聘会计师事务所的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 拟聘任的会计师事务所名称：天健会计师事务所（特殊普通合伙） 一、拟聘任会计师事务所基本情况 （一）机构信息 1、基本信息 | 事务所名称 | 天健会计师事务所（特殊普通合伙） | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 成立日期 | 2011 年 18 日 | 7 | 月 | 组织形式 | | 特殊普通合伙 | | | 注册地址 | 浙江省杭州市西湖区灵隐街道西溪路 128 号 | | | | | | | | 首席合伙人 | 王国海 上年末合伙人数量 | | | | | 238 | 人 | | 上年末执业人 | 注册会计师 | | | | | 2,272 | 人 | | 员数量 | 签署过证券服务业务审计报告的注册会计师 | | | | | 83 ...

杭州景业智能科技股份有限公司 会计师事务所选聘制度 第一章 总则 第一条 为规范杭州景业智能科技股份有限公司（以下简称"公司"）选聘（含续聘、 改聘）会计师事务所的行为，切实维护股东利益，提高财务信息质量，根据《中华人民共和 国公司法》（以下简称"《公司法》"）《中华人民共和国证券法》（以下简称"《证券 法》"）《国有企业、上市公司选聘会计师事务所管理办法》（以下简称"《选聘管 理办法》"）等有关法律法规和规范性文件，以及《杭州景业智能科技股份有限公司章程》 （以下简称"《公司章程》"）的规定，制定本制度。 第二条 公司选聘（含续聘、改聘）对公司进行会计报表审计等业务的会计师事务所 （下称"会计师事务所"），需遵照本制度的规定。 第三条 公司选聘会计师事务所时，应经董事会和股东大会审议。提交董事会审议 前，应经审计委员会全体成员过半数同意。公司不得在董事会、股东大会审议前聘请会计师 事务所开展审计业务。 第四条 公司控股股东、实际控制人不得在公司董事会、股东大会审议前，向公司 指定会计师事务所，也不得干预审计委员会独立履行审核职责。 第二章 会计师事务所执业质量要求 第五条 公司选聘的会计师事务所应当具有证券 ...

杭州景业智能科技股份有限公司 审计委员会对会计师事务所履行监督职责情况报告 根据《公司法》《证券法》《上市公司治理准则》《国有企业、上市公司选聘 会计师事务所管理办法》等规定和要求，董事会审计委员会本着勤勉尽责的原则， 恪尽职守，认真履职。现将董事会审计委员会对会计师事务所履行监督职责的情况 汇报如下： 一、2023年年审会计师事务所基本情况 （一）会计师事务所基本情况 天健会计师事务所（特殊普通合伙）（以下简称"天健所"）成立于2011年7 月，注册地址为浙江省杭州市西湖区灵隐街道西溪路128号，首席合伙人为王国海 先生，拥有财政部颁发的会计师事务所执业证书。截至2023年12月31日，天健所合 伙人数量为238人，注册会计师2,272人，其中签署过证券服务业务审计报告的注册 会计师836人。天健所2023年度业务总收入为人民币34.83亿元，其中审计业务收入 人民币30.99亿元；证券业务收入18.40亿元。2023年度上市公司（含A、B股）审计 客户共计675家，收费总额人民币6.63亿元。这些上市公司主要行业涉及制造业， 信息传输、软件和信息技术服务业，批发和零售业，房地产业，建筑业，电力、热 力、燃 ...